Study on How Postoperative Trendelenburg Position Affects Recurrence of Chronic Subdural Hematoma After Surgery

What this Trial Is About

Researchers are studying the effect of using the postoperative Trendelenburg position on the recurrence of chronic subdural hematoma CSH in patients who undergo surgery. This randomized, open-label clinical trial aims to see if positioning patients with their legs elevated and head tilted downward after surgery reduces the chance of CSH coming back. The study also measures patients functional outcomes, adverse events, and comfort levels over a 3-month period. Participants are assigned to one of two groups the control group receives usual care with the patient lying flat after surgery, and the intervention group is positioned in the Trendelenburg posture with 30 leg elevation and 10 head tilt for 24 hours postoperatively. Proper positioning is checked with a goniometer and maintained until drains are removed. Nurses manage drain occlusion if patients get out of bed. Both groups receive standard neurological monitoring and care following surgery. During the study, patients will be closely monitored in the hospital for at least 24 hours. Researchers will assess the recurrence of CSH at 3 months, along with functional ability using the modified Rankin scale, adverse events, and patient comfort using a Likert scale. The trial is conducted in multiple hospital settings and involves regular clinical monitoring and follow-up. Participation lasts through the 3-month post-surgery period to evaluate outcomes and safety.

Effect of the Postoperative Trendelenburg Position on Chronic Subdural Hematoma Recurrence